Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2024 Earnings Call Transcript

Seres Therapeutics, Inc. (NASDAQ:MCRB) Q4 2024 Earnings Call Transcript March 13, 2025

Seres Therapeutics, Inc. beats earnings expectations. Reported EPS is $-0.1, expectations were $-0.17.

Operator: Thank you for standing by. My name is Kate, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q4 2024 Seres Therapeutics Incorporated Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the...